Treatment of Myasthenia Gravis Based on Its Immunopathogenesis

The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care medicine and symptomatic treatments. Its immunopathogenesis is fundamentally a T-cell-dependent autoimmune process resulting from loss of tolerance toward self-antigens in the thymus. Thymectomy is bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jee Young, Park, Kee Duk, Richman, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259491/
https://www.ncbi.nlm.nih.gov/pubmed/22259613
http://dx.doi.org/10.3988/jcn.2011.7.4.173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259491/
https://www.ncbi.nlm.nih.gov/pubmed/22259613
http://dx.doi.org/10.3988/jcn.2011.7.4.173

Ejemplares similares